Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and MonkeysLázaro Gil, Karem Cobas, Laura Lazo, et al.
International Immunology|March 22, 2015
A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeysEdith Suzarte, Lázaro Gil, Iris Valdés, et al.
Vaccine|January 26, 2022
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in miceLaura Lazo, Monica Bequet-Romero, Gilda Lemos, et al.
Vaccine|December 23, 2008
Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidisIris Valdés, Lisset Hermida, Jorge Martín, et al.
Virology|September 29, 2009
A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in miceIris Valdés, Lidice Bernardo, Lázaro Gil, et al.
Immunology and Cell Biology|September 3, 2014
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2Lázaro Gil, Ernesto Marcos, Alienys Izquierdo, et al.
The American Journal of Tropical Medicine and Hygiene|September 19, 2003
Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastorisMaría G Guzmán, Rayner Rodríguez, Rosmari Rodríguez, et al.
Clinical & Translational Immunology|July 28, 2017
The tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infectionLázaro Gil, Laura Lazo, Iris Valdés, et al.
Clinical & Translational Immunology|April 25, 2017
Screening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developersLaura Lazo Vázquez, Edith Suzarte Portal, Jorge Castro Velazco, et al.
Immunology Letters|May 29, 2016
Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune responseErnesto Marcos, Laura Lazo, Lázaro Gil, et al.
Pageof 5